Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#91 / 200 Total
CANF - Can-Fite Biopharma Ltd ADR - Stock Price Chart
TickerCANF [AMEX]
CompanyCan-Fite Biopharma Ltd ADR
CountryIsrael
IndustryBiotechnology
Market Cap11.16MEPS (ttm)-1.86
P/E-EPS this Y51.05%
Forward P/E-EPS next Y24.49%
PEG-EPS past 5Y48.75%
P/S15.09EPS next 5Y-
P/B1.62EPS Q/Q67.30%
Dividend-Sales Q/Q-21.32%
Insider Own-Inst Own9.57%
Insider Trans-Inst Trans-
Short Float0.22%EarningsMar 28/b
Analyst Recom1.00Target Price15.00
Avg Volume19.95K52W Range1.81 - 3.33
May-13-24 07:00AM Can-Fite: 75 Oncologists and Coordinators from Europe US and Israel Participated in a Conference Aimed at Accelerating Patient Enrolment for the Pivotal Phase 3 Advanced Liver Cancer Study (Business Wire)
May-10-24 09:00AM Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV (ACCESSWIRE)
06:23AM Can-Fite receives FDA IND clearance for Phase IIb MASH treatment trial (Clinical Trials Arena)
May-09-24 07:00AM Can-Fite: FDA Grants IND Clearance for Namodenoson to Treat MASH Patients in a Phase IIb Study (Business Wire) +6.03%
May-06-24 07:00AM Can-Fite Received Notice of Allowance from the European Patent Office for the Treatment of Erectile Dysfunction with CF602 (Business Wire)
Apr-29-24 09:00AM Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-25-24 07:00AM Long-term Complete Response to Can-Fite's Namodenoson in Patient with Advanced Liver Cancer: Article Published in a Leading Scientific Journal (Business Wire)
Apr-15-24 07:00AM Can-Fite: Scientific Article Published by KOL Presents Namodenoson as a Promising Drug Candidate to Treat Advanced Liver Cancer and MASH (Business Wire)
Apr-03-24 07:00AM Can-Fite: Submits FDA with an IND Application to Conduct Phase IIb Clinical Trial of Namodenoson in MASH Patients (Business Wire)
Apr-01-24 07:00AM Can-Fite BioPharma, Ltd. to Present at the LD Micro Invitational XIV (Newsfile)
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.
LPA - Logistic Properties of the Americas - Stock Price Chart
TickerLPA [AMEX]
CompanyLogistic Properties of the Americas
CountryUSA
IndustryShell Companies
Market Cap323.12MEPS (ttm)0.05
P/E211.85EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B2.34EPS Q/Q-133.94%
Dividend-Sales Q/Q-
Insider Own91.27%Inst Own2.90%
Insider Trans0.00%Inst Trans-
Short Float0.28%Earnings-
Analyst Recom-Target Price-
Avg Volume25.17K52W Range5.59 - 31.63
Logistic Properties of the Americas develops, builds and operates logistic real estate properties. The company was headquartered in San Rafael de Escazu, Costa Rica.
CVAC - CureVac N.V. - Stock Price Chart
TickerCVAC [NASD]
CompanyCureVac N.V.
CountryGermany
IndustryBiotechnology
Market Cap779.10MEPS (ttm)-1.27
P/E-EPS this Y29.82%
Forward P/E-EPS next Y20.16%
PEG-EPS past 5Y-23.15%
P/S13.41EPS next 5Y-10.76%
P/B1.37EPS Q/Q38.25%
Dividend-Sales Q/Q103.54%
Insider Own59.03%Inst Own7.98%
Insider Trans0.00%Inst Trans-2.60%
Short Float4.79%EarningsApr 24/b
Analyst Recom2.12Target Price8.89
Avg Volume751.76K52W Range2.21 - 12.36
CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy. The company was founded by Ingmar Hoerr and Florian von der Mulbe in 2000 and is headquartered in Tubingen, Germany.
NRXP - NRX Pharmaceuticals Inc - Stock Price Chart
TickerNRXP [NASD]
CompanyNRX Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap33.69MEPS (ttm)-2.11
P/E-EPS this Y45.50%
Forward P/E-EPS next Y3.67%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-350.73%
Dividend-Sales Q/Q-
Insider Own17.80%Inst Own3.90%
Insider Trans0.00%Inst Trans-
Short Float6.18%EarningsMay 14/a
Analyst Recom1.00Target Price50.00
Avg Volume452.04K52W Range1.90 - 12.00
NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hurvitz ChaimDirectorAug 30 '23Buy0.2970,00020,125570,000Sep 11 09:15 AM
Gorovitz AaronDirectorAug 30 '23Buy0.3235,00011,196105,000Sep 11 09:19 AM
Javitt Jonathan CChief ScientistAug 23 '23Buy0.33100,00033,000446,332Aug 24 12:14 PM
Javitt Jonathan CChief ScientistAug 22 '23Buy0.32200,00064,400346,332Aug 23 09:24 AM
NN - NextNav Inc - Stock Price Chart
TickerNN [NASD, RUT]
CompanyNextNav Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap983.70MEPS (ttm)-0.80
P/E-EPS this Y-12.12%
Forward P/E-EPS next Y35.81%
PEG-EPS past 5Y-
P/S241.10EPS next 5Y-
P/B16.41EPS Q/Q-85.29%
Dividend-Sales Q/Q26.02%
Insider Own74.07%Inst Own20.82%
Insider Trans0.91%Inst Trans-7.95%
Short Float36.55%EarningsMay 08/a
Analyst Recom1.67Target Price12.00
Avg Volume974.27K52W Range2.12 - 9.50
NextNav, Inc. develops next-generation positioning, navigation, and timing solutions. Through its Pinnacle system, it provides floor-level altitude service to devices with a barometric pressure sensor. The company was founded by Ganesh Pattabiraman and Arun Raghupathy in May 2021 and is headquartered in McLean, VA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SUBIN NEIL SDirectorMay 15 '24Buy7.6250,000381,0002,265,213May 15 05:20 PM
SUBIN NEIL SDirectorMay 14 '24Buy7.6942,761328,8322,215,213May 15 05:20 PM
Gates Christian D.Chief Financial OfficerMay 14 '24Sale7.6624,831190,205824,985May 15 05:24 PM
Shams SammaadChief Accounting OfficerMay 14 '24Sale7.726,64951,33063,588May 15 05:22 PM
SUBIN NEIL SDirectorMay 13 '24Buy7.5257,239430,4372,172,452May 15 05:20 PM
BRP - The Baldwin Insurance Group Inc. - Stock Price Chart
TickerBRP [NASD, RUT]
CompanyThe Baldwin Insurance Group Inc.
CountryUSA
IndustryInsurance Brokers
Market Cap2.15BEPS (ttm)-0.92
P/E-EPS this Y40.49%
Forward P/E15.72EPS next Y31.47%
PEG-EPS past 5Y-114.39%
P/S1.70EPS next 5Y32.70%
P/B3.55EPS Q/Q237.27%
Dividend-Sales Q/Q15.11%
Insider Own1.67%Inst Own96.55%
Insider Trans-22.37%Inst Trans-3.39%
Short Float6.06%EarningsMay 07/a
Analyst Recom1.89Target Price35.14
Avg Volume370.47K52W Range17.33 - 32.00
Baldwin Insurance Group, Inc. engages in the provision of insurance services. It operates through the following segments: Insurance Advisory Solutions, Underwriting, Capacity & Technology Solutions, and Mainstreet Insurance Solutions. The Insurance Advisory Solutions segment provides private risk management, commercial risk management, and employee benefits solutions for mid-to-large size businesses and high net worth individuals and families. The Underwriting, Capacity & Technology Solutions segment represents a wholesale co-brokerage platform that delivers specialty insurers, professionals, individuals, and niche industry businesses expanded access to exclusive specialty markets, capabilities, and programs requiring complex underwriting and placement. The Mainstreet segment offers personal insurance, commercial insurance, and life and health solutions to individuals and businesses in their communities. The Medicare segment provides consultation for government assistance programs and solutions, including traditional Medicare and Medicare Advantage, to seniors and Medicare-eligible individuals through a network of agents. The company was founded by Elizabeth H. Krystyn, Laura R. Sherman, and Lowry L. Baldwin in 2011 and is headquartered in Tampa, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Roche James MorganSee RemarksMay 13 '24Sale30.615,000153,050233,499May 13 08:49 PM
Galbraith DanielSee RemarksMay 10 '24Sale29.8380,9322,414,2020May 13 08:51 PM
Galbraith DanielSee RemarksMay 10 '24Sale30.1124,841747,9636,285May 13 08:51 PM
Galbraith DanielSee RemarksMay 09 '24Sale30.0374,6682,242,57580,932May 13 08:51 PM
Roche James MorganSee RemarksMay 09 '24Sale30.0620,000601,179238,499May 13 08:49 PM
OPTN - OptiNose Inc - Stock Price Chart
TickerOPTN [NASD, RUT]
CompanyOptiNose Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap186.84MEPS (ttm)-0.27
P/E-EPS this Y21.91%
Forward P/E-EPS next Y73.08%
PEG-EPS past 5Y34.78%
P/S2.52EPS next 5Y-
P/B-EPS Q/Q25.92%
Dividend-Sales Q/Q25.61%
Insider Own28.62%Inst Own44.70%
Insider Trans-0.25%Inst Trans-0.27%
Short Float5.72%EarningsMay 14/b
Analyst Recom1.00Target Price3.50
Avg Volume1.21M52W Range0.80 - 2.10
OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mahmoud Ramy AChief Executive OfficerMar 18 '24Sale1.8819,19836,0921,331,278Mar 19 12:43 PM
Marino Michael F IIIChief Legal Officer & Corp SecMar 18 '24Sale1.8815,05928,311602,268Mar 19 12:45 PM
Krick Anthony JChief Accounting OfficerMar 18 '24Sale1.882,3454,409143,988Mar 19 12:46 PM
Mahmoud Ramy AChief Executive OfficerJan 31 '24Sale1.3152,87569,266548,387Feb 01 02:43 PM
Mahmoud Ramy AChief Executive OfficerDec 18 '23Sale1.1511,11412,781509,728Dec 20 12:21 PM
KRUS - Kura Sushi USA Inc - Stock Price Chart
TickerKRUS [NASD, RUT]
CompanyKura Sushi USA Inc
CountryUSA
IndustryRestaurants
Market Cap1.30BEPS (ttm)0.14
P/E847.92EPS this Y80.78%
Forward P/E182.61EPS next Y151.16%
PEG-EPS past 5Y-7.54%
P/S6.12EPS next 5Y-
P/B7.88EPS Q/Q13.80%
Dividend-Sales Q/Q30.37%
Insider Own45.81%Inst Own63.29%
Insider Trans-0.38%Inst Trans11.85%
Short Float26.41%EarningsApr 04/a
Analyst Recom2.00Target Price113.00
Avg Volume119.04K52W Range51.02 - 122.81
Kura Sushi USA, Inc. engages in the operation of technology-enabled Japanese restaurants. It offers a distinctive dining experience by serving authentic Japanese cuisine through an engaging revolving sushi service model. The company was founded by Hajime Uba in 2008 and is headquartered in Irvine, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ISHII SEITARODirectorApr 12 '24Option Exercise25.945,000129,7006,313Apr 16 09:45 PM
ISHII SEITARODirectorApr 12 '24Sale109.975,000549,8711,313Apr 16 09:45 PM
TAKAO BRENTSee Remarks (a)Jan 12 '24Option Exercise25.9414,422374,10711,109Jan 17 08:00 PM
TAKAO BRENTSee Remarks (a)Jan 12 '24Sale88.9714,4221,283,1761,687Jan 17 08:00 PM
STUTZ CARINDirectorNov 13 '23Buy52.371,50078,5552,654Nov 15 04:01 PM
ADN - Advent Technologies Holdings Inc - Stock Price Chart
TickerADN [NASD]
CompanyAdvent Technologies Holdings Inc
CountryUSA
IndustryUtilities - Renewable
Market Cap8.68MEPS (ttm)-7.45
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-1240.46%
P/S1.63EPS next 5Y-
P/B0.21EPS Q/Q-2551.62%
Dividend-Sales Q/Q-47.31%
Insider Own-Inst Own5.91%
Insider Trans-Inst Trans-3.35%
Short Float-EarningsNov 14/b
Analyst Recom3.00Target Price13.50
Avg Volume49.86K52W Range2.77 - 33.90
Advent Technologies Holdings, Inc. operates as an advanced materials and technology development company. It develops, manufactures and assembles hydrogen fuel cell components. The company was founded on June 18, 2018 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brackman Kevin L.CFOSep 06 '23Sale0.5327,77114,746176,477Sep 08 05:00 PM
Gregoriou VassiliosCEO, ChairSep 06 '23Sale0.5314,1577,5176,367,669Sep 08 05:00 PM
MAIA - MAIA Biotechnology Inc - Stock Price Chart
TickerMAIA [AMEX]
CompanyMAIA Biotechnology Inc
CountryUSA
IndustryBiotechnology
Market Cap68.14MEPS (ttm)-1.53
P/E-EPS this Y-6.02%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-25.01%
P/S-EPS next 5Y-
P/B-EPS Q/Q-22.21%
Dividend-Sales Q/Q-
Insider Own21.50%Inst Own2.76%
Insider Trans15.21%Inst Trans111.02%
Short Float5.90%EarningsNov 07/b
Analyst Recom1.00Target Price14.00
Avg Volume376.24K52W Range0.82 - 3.59
MAIA Biotechnology, Inc. is a clinical stage biotechnology company that is engaged in the discovery, development and commercialization of therapies targeting cancer. Its product, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded on August 3, 2018 and is headquartered in Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smith StanDirectorApr 25 '24Buy2.03147,492299,4091,005,060Apr 26 05:30 PM
Louie Ngar YeeDirectorApr 25 '24Buy2.0319,66539,9201,167,189Apr 26 05:33 PM
Smith StanDirectorMar 14 '24Buy1.17170,940200,000857,568Mar 15 07:11 PM
Louie Ngar YeeDirectorMar 14 '24Buy1.17170,940200,0001,147,524Mar 15 07:09 PM
Luput CristianDirectorMar 14 '24Buy1.1769,28281,060367,350Mar 15 07:08 PM
15678910111213141520